The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014)

…, H Matsuura, K Miura, R Morishita… - Hypertension …, 2014 - keio.elsevierpure.com
… Kazuaki Shimamoto, Katsuyuki Ando, Toshiro Fujita, Naoyuki Hasebe, Jitsuo Higaki,
Masatsugu Horiuchi, Yutaka Imai, Tsutomu Imaizumi, Toshihiko Ishimitsu, Masaaki Ito …

In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

R Morishita, T Sugimoto, M Aoki, I Kida, N Tomita… - Nature medicine, 1997 - nature.com
The transcriptional factor nuclear factor-κB (NFκB) plays a pivotal role in the coordinated
trans-activation of cytokine and adhesion molecule genes that might be involved in myocardial …

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

…, GH Gibbons, R Morishita… - Proceedings of the …, 1995 - National Acad Sciences
It is postulated that vascular disease involves a disturbance in the homeostatic balance of
factors regulating vascular tone and structure. Recent developments in gene transfer …

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

…, H Tsutsui, K Nakanishi, Y Sawa, R Morishita… - Nature medicine, 1999 - nature.com
Liver cirrhosis is the irreversible end result of fibrous scarring and hepatocellular regeneration,
characterized by diffuse disorganization of the normal hepatic structure of regenerative …

Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy

H Nakagami, R Morishita, K Maeda… - … of atherosclerosis and …, 2006 - jstage.jst.go.jp
Adult stem cells hold great promise for use in tissue repair and regeneration, and there has
been continuing interest in both the biology and potential therapeutic applications of adult …

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

R Morishita, GH Gibbons, M Horiuchi… - Proceedings of the …, 1995 - National Acad Sciences
The application of DNA technology to regulate the transcription of disease-related genes in
vivo has important therapeutic potentials. The transcription factor E2F plays a pivotal role in …

Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model

…, XR Huang, JH Li, HJ Zhu, R Morishita… - Journal of the …, 2003 - journals.lww.com
ABSTRACT. TGF-β is a key mediator in renal fibrosis. Kidney-targeted gene therapy with
anti–TGF-β strategies is expected to have therapeutic potential, but this has been hampered by …

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

…, W Hayashida, R Morishita… - Proceedings of the …, 1995 - National Acad Sciences
The type 1 angiotensin II (AT1) receptor is well characterized but the type 2 (AT2) receptor
remains an enigma. We tested the hypothesis that the AT2 receptor can modulate the growth …

Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue–derived stromal cells

H Nakagami, K Maeda, R Morishita… - … , and vascular biology, 2005 - Am Heart Assoc
Objective— The delivery of autologous progenitor cells into ischemic tissue of patients is
emerging as a novel therapeutic option. Here, we report the potential impact of cultured …

Local delivery of plasmid DNA into rat carotid artery using ultrasound

…, M Aoki, T Ogihara, K Yasufumi, R Morishita - Circulation, 2002 - Am Heart Assoc
Background— Although viral vector systems are efficient to transfect foreign genes into
blood vessels, safety issues remain in relation to human gene therapy. In this study, we …